Trial · NCT07268170
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
NCT07268170, Phase 2, Phase 3, Enrolling by invitation, Gødstrup Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease. Trials, record NCT07268170. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07268170
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
- NCT number
- NCT07268170
- Status
- Enrolling by invitation
- Phases
- Phase 2, Phase 3
- Enrollment
- 350 participants, estimated
- Lead sponsor
- Gødstrup Hospital
- Conditions
- Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)
- Interventions
- atenolol, Metoprolol tartrate, Ivabradine, Atenolol/Metoprolol tartrate, Ivabradine 7.5/15 mg
- First posted
- 2025-12-05
- Last updated
- 2025-12-17
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dose and type of drugs with the swiftest heart rate reduction in patients undergoing cardiac computed tomography | From adminstration of study drug to start af cardiac computed tomography, 2 hours | Time in minutes to heart rate (mean) lowered by 10% from baseline after administration of study drug |
| Secondary | Proportion of patients with heart rate <60 beats per minute | From adminstration of study drug to start af cardiac computed tomography, 2 hours | |
| Secondary | Total heart rate reduction in beats per minute after 120 minutes | From adminstration of study drug to start af cardiac computed tomography, 2 hours | |
| Secondary | Number of patients in need of an intravenous betablocker | From adminstration of study drug to start af cardiac computed tomography, 2 hours | Patients with a heart rate \>60 beats per minutes after 2 hours after administration of study drug |
| Secondary | Efficacy of intravenous administration of betablocker | From adminstration of study drug to start af cardiac computed tomography, 2 hours | How patients tolerate intravenous betablocker |
| Secondary | Evaluation of side effects, safety, and tolerability of metoprolol, atenolol, and ivabradine | From intervention af study drug to phone contact to patient 1 week after cardiac computed tomography | Phone contact to patient to describe any side effects and the tolerability |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07268170
GET https://conductscience.org/api/trials/v1/NCT07268170/registered